# Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®)

> **NCT01032954** · PHASE4 · COMPLETED · sponsor: **Hexsel Dermatology Clinic** · enrollment: 90 (actual)

## Conditions studied

- Sun-induced Wrinkles

## Interventions

- **DRUG:** Botulinum toxin

## Key facts

- **NCT ID:** NCT01032954
- **Lead sponsor:** Hexsel Dermatology Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032954, "Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01032954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*